← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

A

$ Value

$0

Shares

14,684

Price

$0

Filed

Jan 5

Insider

Name

Chan Gerald

Title

CIK

0001636579

Roles

Director

Transaction Details

Transaction Date

2026-01-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,684

Footnotes

This restricted stock unit was granted on January 1, 2026. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election. | This option was granted on January 1, 2026. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant.

Filing Info

Accession No.

0001492422-26-000012

Form Type

4

Issuer CIK

0001492422

Chan Gerald's History

Date Ticker Type Value
2026-01-01 APLS A $0
2026-01-01 APLS A $0

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28